| Patents for A61P 17 - Drugs for dermatological disorders (106,455) |
|---|
| 03/16/2011 | EP2295060A2 Stabilization of hypoxia inducible factor (HIF) alpha |
| 03/16/2011 | EP2295059A2 Stabilization of hypoxia inducible factor (HIF) alpha |
| 03/16/2011 | EP2295055A2 (+)-2-[1-(3-Ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione: Methods of using and compositions thereof |
| 03/16/2011 | EP2295051A1 Wound healing compound |
| 03/16/2011 | EP2295032A1 Ceramide dispersion |
| 03/16/2011 | EP2295028A1 Preparation for preventing or ameliorating wrinkles, to be taken orally, through injection, or through external application to skin, and cosmetic method |
| 03/16/2011 | EP2294917A1 Transgenic animals expressing antibodies specific for genes of interest and uses thereof |
| 03/16/2011 | EP2294428A1 A polymer adapted to release bioactive agents in vivo, pharmaceutical composition and method of preparation thereof |
| 03/16/2011 | EP2294055A1 Salts comprising a pyrimidinecarboxylic acid derivative for cosmetic use |
| 03/16/2011 | EP2293847A1 Depsipeptides and their therapeutic use |
| 03/16/2011 | EP2293795A1 Pharmaceutical combination |
| 03/16/2011 | EP2293771A2 Novel inverse latices that are free of oxyethylene derivatives, and cosmetic, dermocosmetic, dermopharmaceutical or pharmaceutical compositions comprising same |
| 03/16/2011 | EP2293770A2 Novel inverse latices based on fatty alcohol ethers, and cosmetic, dermocosmetic, dermopharmaceutical or pharmaceutical compositions comprising same |
| 03/16/2011 | EP2293761A2 Compositions for topical application comprising microencapsulated colorants |
| 03/16/2011 | EP2293677A1 Nutritional composition for infants delivered via caesarean section |
| 03/16/2011 | EP2083796B1 Metal coated nanoparticles for use in the treatment of enzymatic dermatitis |
| 03/16/2011 | EP2057165B1 Acyclic amine inhibitors of nucleoside phosphorylases and hydrolases |
| 03/16/2011 | EP1448535B1 Benzamide and heteroarylamide as p2x7 receptor antagonists |
| 03/16/2011 | EP1359938B1 Method for treating psoriasis by using an il-17d antagonist |
| 03/16/2011 | CN201758886U Health care inner sole |
| 03/16/2011 | CN1939324B Medical usage of periplocin A and E |
| 03/16/2011 | CN1931283B Orally taken pearl liquid and its production process |
| 03/16/2011 | CN101986782A Substituted heteroarylamide diazepinopyrimidone derivatives |
| 03/16/2011 | CN101985471A Folate-IgG conjugate as well as preparation method and application thereof |
| 03/16/2011 | CN101985021A Skin nourishing cream |
| 03/16/2011 | CN101985011A Blackening powder for grey hairs |
| 03/16/2011 | CN101985009A Chinese medicinal composition for treating chronic urticaria |
| 03/16/2011 | CN101984999A Healing powder |
| 03/16/2011 | CN101984998A Juices for growing new hairs for hairless person |
| 03/16/2011 | CN101984996A Liquid for treating ringworm of feet |
| 03/16/2011 | CN101984995A Traditional Chinese medicine composition for treating infant eczema |
| 03/16/2011 | CN101984991A Powder for treating eczema of scrotum |
| 03/16/2011 | CN101984985A Epilepsy removal juice |
| 03/16/2011 | CN101984981A Linimentum containing mussel polysaccharide, preparation method and application thereof |
| 03/16/2011 | CN101810706B Preparation method of garden burnet solid preparation with low dose |
| 03/16/2011 | CN101612291B Medicine composition for treating psoriasis |
| 03/16/2011 | CN101559063B External medicament for curing herpes zoster and preparation method thereof |
| 03/16/2011 | CN101559038B Solid lipid nanoparticles of finasteride and preparation method thereof |
| 03/16/2011 | CN101502609B Chinese medicament preparation for cooling blood and dissolving stasis |
| 03/16/2011 | CN101502588B Composition for beauty treatment and removing blain and method for preparing the same |
| 03/16/2011 | CN101491520B Local application medicine formulation |
| 03/16/2011 | CN101485786B Whitening spot-eliminating composition and method for preparing the same |
| 03/16/2011 | CN101475648B Preparation of Mallotus furetianus polysaccharide |
| 03/16/2011 | CN101322797B Chinese medicine agent for treating armpit odor |
| 03/16/2011 | CN101306097B Zengkangning tablets quality control method |
| 03/16/2011 | CN101264130B Film coating agent for treating skin ulcer |
| 03/16/2011 | CN101254277B External application paste for curing empyrosis |
| 03/16/2011 | CN101167847B Traditional Chinese medicinal white spirit preparation for effectively treating skin disease |
| 03/15/2011 | US7906659 Carbocyclic and oxacarbocyclic fumaric acid oligomers |
| 03/15/2011 | US7906650 Caspase inhibitors and uses thereof |
| 03/15/2011 | US7906644 2,4-pyrimidinediamine compounds and their uses |
| 03/15/2011 | US7906616 Truncated DANCE, DANCE complex and method of using these |
| 03/15/2011 | US7906557 Oral preventive/therapeutic agent for skin damage containing diacylglyceryl ether |
| 03/15/2011 | US7906523 retrovirus inhibor; anticarcinogenic, antidiabetic agent, immunosuppressant, autoimmune diseases; 2-{6-[3(R)-Amino-piperidin-1-yl]-3-methyl-2,4-dioxo-3,4-dihydro-2H-pyrimidin-1-ylmethyl}-4-fluoro-benzonitrile; type 2 diabetes mellitus, impaired glucose tolerance, obesity, multiple sclerosis |
| 03/15/2011 | CA2473160C Composition for pharmaceutical or dietetic use for combating hair loss |
| 03/15/2011 | CA2470703C Oral pharmaceutical products containing 17.beta.-estradiol-3-lower alkanoate, method of administering the same and process of preparation |
| 03/15/2011 | CA2458266C Substituted urea retinoid agonists ii |
| 03/15/2011 | CA2443235C Pharmaceutical compositions comprising ascomycin |
| 03/15/2011 | CA2433806C Methods for treating autoimmune diseases in a subject and in vitro diagnostic assays |
| 03/15/2011 | CA2431160C Anilinopyrimidine derivatives as ikk inhibitors and compositions and methods related thereto |
| 03/15/2011 | CA2429935C Compositions and methods for treating hyperpigmentation |
| 03/15/2011 | CA2406008C Composition exhibiting enhanced formulation stability and delivery of topical active ingredients |
| 03/15/2011 | CA2402038C Lpa receptor agonists and antagonists and methods of use |
| 03/15/2011 | CA2397681C Partially saturated calcium channel blockers |
| 03/15/2011 | CA2360415C Benzimidazole vascular damaging agents |
| 03/15/2011 | CA2277192C Nuclear transfer with differentiated fetal and adult donor cells |
| 03/15/2011 | CA2271762C Use of sphingomyelinase to increase the levels of skin and mucosal ceramides, and dermatological and cosmetic compositions suitable for topical application containing same |
| 03/15/2011 | CA2232191C Inhibition of tumor necrosis factor alpha |
| 03/10/2011 | WO2011028811A2 Dual variable domain immunoglobulins and uses thereof |
| 03/10/2011 | WO2011028673A2 A composition for delaying cellular senescence |
| 03/10/2011 | WO2011028542A2 Methods of treating pain associated with complex regional pain syndrome |
| 03/10/2011 | WO2011028112A1 Imidazole-4-carboxylic acid for use in treating a disease related to extracellular reactive oxygen species |
| 03/10/2011 | WO2011028110A1 Composition for topical application, uses thereof, applicator device and kit of parts |
| 03/10/2011 | WO2011027916A1 Therapeutic agent for allergic diseases |
| 03/10/2011 | WO2011027348A1 Pharmaceutical composition comprising a3 adenosine receptor agonist (ib-meca/cf-101) for treatment of psoriasis |
| 03/10/2011 | WO2011027128A1 Use of non-digestible oligosaccharides |
| 03/10/2011 | WO2011027048A1 Transglutaminase-activating peptide, and cosmetic or pharmaceutical composition containing same |
| 03/10/2011 | WO2011026781A1 Novel multifunctional peptidase inhibitors, especially for medical use |
| 03/10/2011 | WO2010135527A9 Elastin for soft tissue augmentation |
| 03/10/2011 | WO2010129321A3 Topical compositions comprising an alkoxylated diphenylacrylate compound and an aryl carboxylic ester |
| 03/10/2011 | WO2010126348A3 Solution for preventing hair loss and activating hair growth |
| 03/10/2011 | WO2010124296A3 Compositions containing hc•ha complex and methods of use thereof |
| 03/10/2011 | WO2010117170A3 Pharmaceutical composition for treating or preventing burn injuries |
| 03/10/2011 | WO2010074721A3 Anitmicrobial agents, compositions and products containing the same, and methods of using the compositions and products |
| 03/10/2011 | US20110060195 Cosmetic treatment method for treating the scalp |
| 03/10/2011 | US20110060130 Neutralizing human anti-igfr antibody |
| 03/10/2011 | US20110060043 Inhibitors of cell proliferation and uses thereof |
| 03/10/2011 | US20110060042 External preparation for skin |
| 03/10/2011 | US20110060041 Method of reversing, preventing, delaying or stabilizing soft tissue calcification |
| 03/10/2011 | US20110060026 Indoles Active on CRTH2 Receptor |
| 03/10/2011 | US20110060014 Methods and compositions using stearoyl-CoA desaturase to identify triglyceride reducing therapeutic agents |
| 03/10/2011 | US20110060012 4-[3-(aryloxy)benzylidene]-3-methyl piperidine 5-membered aryl carboxamide compounds useful as faah inhibitors |
| 03/10/2011 | US20110060010 Salts of 3-(4-amino-1-oxo-1,3-dihydro-isoindol-2-yl)piperidine-2,6-dione and derivatives thereof, or polymorphs of salts, process for preparing same and use thereof |
| 03/10/2011 | US20110060007 Novel NIP Thiazole Derivatives as Inhibitors of 11-Beta-Hydroxysteroid Dehydroge-Nase-1 |
| 03/10/2011 | US20110059999 Hydroxymethylcyclohexylamines |
| 03/10/2011 | US20110059985 Novel formulation |
| 03/10/2011 | US20110059969 Piperazines as anti-obesity agents |
| 03/10/2011 | US20110059967 Therapeutic compounds |
| 03/10/2011 | US20110059963 Compounds and methods for kinase modulation, and indications therefor |
| 03/10/2011 | US20110059959 Novel multicyclic compounds and the use thereof |